RALLYBIO
Rallybio is a clinical-stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare diseases. Since its launch in January 2018, Rallybio has built a portfolio of promising product candidates, which are now in development to address rare diseases in the areas of hematology, immuno-inflammation, maternal fetal health and metabolic disorders. The Company’s mission is being advanced by a team of highly experienced biopharma industry leaders with extensive research, development, and rare disease expertise.
RALLYBIO
Social Links:
Industry:
Biopharma Biotechnology Health Care Therapeutics
Founded:
2018-01-01
Address:
Farmington, Connecticut, United States
Country:
United States
Website Url:
http://www.rallybio.com
Total Employee:
11+
Status:
Active
Contact:
(203) 859-3820
Total Funding:
182 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Affinia Therapeutics
Affinia Therapeutics is a biotechnology company developing transformative AAV gene therapies for people with devastating diseases.
Berkeley Lights
Berkeley Lights is a provider of research and development services using micro-droplet technology that change the biological processes.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Cellestia
Cellestia is a clinical stage R&D company developing innovative first-in-class therapies to control and modulate pathogenic gene expression.
D2G Oncology
D2G Oncology is a biotechnology company that specializes in relating drugs to genotypes to transform precision cancer therapeutics.
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Global Investment Partners
Global Investment Partners investment in Series B - Rallybio
Canaan Partners
Canaan Partners investment in Series B - Rallybio
New Leaf Venture Partners
New Leaf Venture Partners investment in Series B - Rallybio
5AM Ventures
5AM Ventures investment in Series B - Rallybio
Fairview Capital Partners
Fairview Capital Partners investment in Series B - Rallybio
Solasta Ventures
Solasta Ventures investment in Series B - Rallybio
The Rise Fund
The Rise Fund investment in Series B - Rallybio
Mitsui Global Investment
Mitsui Global Investment investment in Series B - Rallybio
F-Prime Capital
F-Prime Capital investment in Series B - Rallybio
Pivotal bioVenture Partners
Pivotal bioVenture Partners investment in Series B - Rallybio
Official Site Inspections
http://www.rallybio.com Semrush global rank: 10.39 M Semrush visits lastest month: 1
- Host name: 104.21.64.1
- IP address: 104.21.64.1
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Rallybio"
Rallybio
The RLYB116 confirmatory PK/PD study is expected to provide evidence that Rallybio’s C5 inhibitor has the potential to be best-in-class for patients with complement-mediated diseases. See the Details Change jobs. Then change …See details»
Rallybio - Crunchbase Company Profile & Funding
Rallybio is a clinical-stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with …See details»
Rallybio - LinkedIn
Rallybio (NASDAQ: RLYB) is a clinical-stage biotechnology company with a mission to develop and commercialize life-transforming therapies for patients with severe and rare diseases.See details»
Investor Relations | Rallybio
Feb 25, 2025 Rallybio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates. PDF Version. Feb 25, 2025 Rallybio to Present at the TD Cowen …See details»
Rallybio - Funding, Financials, Valuation & Investors - Crunchbase
Rallybio is registered under the ticker NASDAQ:RLYB . Their stock opened with $13.00 in its Jul 28, 2021 IPO. Rallybio is funded by 14 investors. Johnson & Johnson Innovation – JJDC and …See details»
Rallybio Corporation - AnnualReports.com
Rallybio (NASDAQ: RLYB) is a clinical-stage biotechnology company with a mission to develop and commercialize life-transforming therapies for patients with severe and rare diseases. Rallybio has built a broad pipeline of promising …See details»
CREATING PATHS FORWARD - Rallybio
Rallybio Rallybio (NASDAQ: RLYB) is a clinical-stage biotechnology company with a mission to develop and commercialize life-transforming therapies for patients with severe and rare …See details»
Rallybio - Contacts, Employees, Board Members, Advisors & Alumni
Rallybio is an biotechnological research and development services intended to transform the lives of patients with a devastating disease. ... Experience the new Crunchbase, powered by AI . …See details»
Rallybio - VentureRadar
Rallybio was established to identify and accelerate the development of transformative breakthrough therapies for patients with severe and rare disorders. The founders of the …See details»
Rallybio - 2025 Company Profile, Funding & Competitors - Tracxn
Mar 11, 2025 Rallybio - Developer of antibodies & protein therapies for rare disorders. Public Company. Raised a total funding of $182M over 3 rounds from 13 investors. Founded by …See details»
Rallybio - Fierce Pharma
But that’s not stopping New Haven, Connecticut-based Rallybio from rallying scientists and experts against fetal and neonatal alloimmune thrombocytopenia (FNAIT).See details»
Driving the Vision: Rallying for our Culture and People - LinkedIn
Feb 9, 2023 Famous Black History maker George Washington Carver said, "where there is no vision, there is no hope." Therefore, keeping people and culture at the forefront of your …See details»
Mission, Vision & Core Values of Rallybio – …
Dec 12, 2024 Rallybio's Mission Statement. At Rallybio, our mission is to transform the lives of patients with devastating diseases through innovative biotechnological research and …See details»
Our Vision: Why We Rally Every Day - LinkedIn
Oct 11, 2022 Rallybio has come a long way since 2017 with several drugs in the clinic and several more in the pipeline. We have raised over $237M and done four deals to support our …See details»
Rallybio Corp - Company Profile - GlobalData
Rallybio Corp (Rallybio) is a clinical-stage biotechnology company committed on discovering and accelerating the development of life-transforming therapies for patients with severe and rare …See details»
Rallybio Completes $145 Million Series B Financing and …
May 19, 2020 Rallybio is a biopharmaceutical company focused on identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. …See details»
Who Owns Rallybio – CanvasBusinessModel.com
Dec 12, 2024 Impact of Ownership on Rallybio's Direction. Ownership plays a significant role in shaping the direction of a company like Rallybio. The decisions made by the owners, whether …See details»
New Haven-based Rallybio discontinues development of rare …
Apr 8, 2025 Rallybio, a New Haven-based biotechnology firm, said Tuesday it has discontinued development of a therapy intended to prevent a rare immune disorder in fetuses and …See details»
Rallybio scores $145M, unveils lead rare disease program
May 19, 2020 Rallybio found the program, now called RLYB-211, in a worldwide search for assets, acquiring it from a tiny startup in Norway. It’s designed to treat fetal and neonatal …See details»
Rallybio ESG Guidelines Updated 14Dec2022 DRAFT CLEAN
SASB is a non-profit organization that sets forth ESG disclosure standards and frameworks. Alignment to the above standards will enable third-party rating agencies to give Rallybio a fair …See details»